Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT05036005
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2021-08-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
Sponsor:
Institut fuer Frauengesundheit
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-30
First Submit QC Date:
None
Study First Post Date:
2021-09-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-14
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL